Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.55 USD | -0.36% | +2.02% | -13.17% |
05-15 | US FDA approves expanded use of Bristol's cancer cell therapy | RE |
05-15 | Transcript : Bristol-Myers Squibb Company Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.17% | 90.31B | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- HSBC Upgrades Bristol-Myers Squibb to Hold From Reduce, Cuts Price Target to $53 From $55